9.18
Anika Therapeutics Inc (ANIK) 財務データ
損益計算書
四半期ごと
*すべての数値は百万単位です
期間終了日 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
Revenues |
7.84%
28.22
|
26.17 | -1.29 | 38.75 | 41.92 |
Cost Of Revenue |
20.62%
13.86
|
11.49 | -23.86 | 37.31 | 14.56 |
Gross Profit |
2.17%
14.36
|
14.68 | 22.57 | 1.44 | 27.36 |
|
2.23%
18.54
|
18.96 | -5.253 | 29.46 | 27.20 |
Benefits Costs and Expenses |
7.15%
32.19
|
30.04 | -29.85 | 66.36 | 41.16 |
Costs And Expenses |
2.23%
18.54
|
18.96 | -5.253 | 29.46 | 27.20 |
Depreciation and Amortization |
7.45%
1.28
|
1.383 | 1.56 | 1.86 | 1.73 |
Operating Income/Loss |
2.43%
-4.18
|
-4.284 | 27.82 | -28.02 | 0.161 |
Income/Loss From Continuing Operations Before Tax |
2.51%
-3.966
|
-3.869 | 28.56 | -27.61 | 0.756 |
Income Tax Expense/Benefit, Deferred |
116.67%
-0.003
|
0.018 | 0.234 | -0.184 | 0.017 |
Income Tax Expense/Benefit |
665.17%
0.681
|
0.089 | 2.87 | 2.307 | 0.844 |
Income/Loss From Continuing Operations After Tax |
17.41%
-4.647
|
-3.958 | 25.69 | -29.92 | -0.088 |
Income/Loss From Discontinued Operations, Net Of Tax |
173.99%
0.677
|
-0.915 | - | - | - |
|
18.53%
-3.97
|
-4.873 | -21.86 | -29.92 | -0.088 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.47%
14.36
|
14.30 | -0.048 | 14.77 | 14.84 |
Diluted Average Shares |
1.54%
14.52
|
14.30 | -0.048 | 14.77 | 14.84 |
Basic Earnings Per Share |
17.65%
-0.28
|
-0.34 | -1.49 | -2.03 | -0.01 |
Diluted Earnings Per Share |
17.65%
-0.28
|
-0.34 | -1.49 | -2.03 | -0.01 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
大文字化:
|
ボリューム (24 時間):